-
Product Insights
Carcinoid Tumor - Drugs In Development, 2024
Empower your strategies with our Carcinoid Tumor – Drugs In Development, 2024 report and make more profitable business decisions. Carcinoid tumors are slow-growing tumors arising from neuroendocrine cells and capable of secreting a variety of peptides and neuroamines. The common primary sites are the gastrointestinal (GI) tract, tracheobronchial tree, ovaries, and kidneys. The most common location of carcinoids is the small intestine. The term carcinoid is usually used for well-differentiated and low- to intermediate-grade neuroendocrine tumors. The Carcinoid Tumor drugs in...
-
Product Insights
Craniopharyngioma - Drugs In Development, 2024
Empower your strategies with our Craniopharyngioma – Drugs In Development, 2024 report and make more profitable business decisions. Craniopharyngioma is a brain tumor that develops near the pituitary gland and the hypothalamus and is slow-growing and non-cancerous. Although these tumors are not cancerous, they may grow to press on nearby parts of the brain, causing symptoms including hormonal changes, vision alteration, headaches, nausea and vomiting, loss of balance, hearing loss, and changes in mood or behavior. The cause of these tumors...
-
Product Insights
Nongerminomatous (Nonseminomatous) Germ Cell Tumors - Drugs In Development, 2024
Empower your strategies with our Nongerminomatous (Nonseminomatous) Germ Cell Tumors – Drugs In Development, 2024 report and make more profitable business decisions. The most common type of testis cancer is a germ cell tumor (GCT). There are two main types of GCT, seminoma and nonseminomatous germ cell tumor (NSGCT). Both seminoma and NSGCT occur at about the same rate, and men can have seminoma, NSGCTs, or a combination of both. There are four main types of NSGCT that can appear alone,...
-
Product Insights
Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal Cell Carcinoma Syndrome) - Drugs In Development, 2024
Empower your strategies with our Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal Cell Carcinoma Syndrome) – Drugs In Development, 2024 report and make more profitable business decisions. Gorlin syndrome, also known as basal cell nevous syndrome, is a condition that affects many areas of the body and increases the risk of developing various cancerous and noncancerous tumors. Symptoms include arrhythmia, medulloblastoma, ovarian fibromas, depressions in the skin, large head size and skeletal abnormalities involving the spine, ribs, or skull. Treatment...
-
Product Insights
Hormone Sensitive Breast Cancer - Drugs In Development, 2024
Empower your strategies with our Hormone Sensitive Breast Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Estrogen and progesterone promote the growth of some breast cancers, which are called hormone-sensitive (or hormone-dependent) breast cancers. Hormone-sensitive breast cancer cells contain proteins called hormone receptors (estrogen receptors, or ERs, and progesterone receptors, or PRs) that become activated when hormones bind to them. The activated receptors cause changes in the expression of specific genes, which can stimulate cell growth....
-
Product Insights
Primitive Neuroectodermal Tumor (PNET) - Drugs In Development, 2024
Empower your strategies with our Primitive Neuroectodermal Tumor (PNET) – Drugs In Development, 2024 report and make more profitable business decisions. Primitive neuroectodermal tumors (PNET) and pineoblastoma are a group of tumors defined by their appearance and are thought to develop from undeveloped nerve cells in the brain. They are aggressive tumors that tend to attach to parts of the brain that control movement, thought, and sensation. The Primitive Neuroectodermal Tumor (PNET) drugs in development market research report provide comprehensive information...
-
Product Insights
Round Cell Liposarcoma - Drugs In Development, 2024
Empower your strategies with our Round Cell Liposarcoma – Drugs In Development, 2024 report and make more profitable business decisions. Round cell liposarcoma, also called myxoid or MRCLS, is one of several types of liposarcoma. Liposarcoma is a rare cancer that grows in the cells that store fat in the body. MRCLS tumors usually grow in the arms and legs. These tumors grow slowly, and they can spread to other parts of the body. The Round Cell Liposarcoma drugs in development...
-
Product Insights
Acute Lymphoblastic Lymphoma - Drugs In Development, 2024
Empower your strategies with our Acute Lymphoblastic Lymphoma – Drugs In Development, 2024 report and make more profitable business decisions. Acute lymphoblastic lymphoma (ALL) is a heterogeneous hematologic malignancy involving proliferation of lymphoid progenitor cells (of B cell or T cell lineage) that invades bone marrow, peripheral blood, and extramedullary locations. ALL is a disease with ≥ 20% of lymphoblasts (atypical lymphoid or undifferentiated cells) in bone marrow lymphoblasts or peripheral blood. The Acute Lymphoblastic Lymphoma drugs in development market research...
-
Product Insights
Anaplastic Oligoastrocytoma - Drugs In Development, 2024
Empower your strategies with our Anaplastic Oligoastrocytoma – Drugs In Development, 2024 report and make more profitable business decisions. Anaplastic oligoastrocytoma is a brain tumor that forms when two types of cells in the brain, called oligodendrocytes and astrocytes, rapidly increase in number to form a mass. These brain cells are known as glial cells, which normally protect and support nerve cells in the brain. Symptoms include seizures, headaches, and personality changes. Other symptoms vary by location and size of the...
-
Product Insights
Duodenal Cancer - Drugs In Development, 2024
Empower your strategies with our Duodenal Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Duodenal cancer is a type of malignancy that develops in the duodenum, which is a part of the small intestine. A malignancy involves cancerous cells that can metastasize (spread to other sites or invade and destroy nearby tissues). The most common type of duodenal cancer is adenocarcinoma. The Duodenal Cancer drugs in development market research report provide comprehensive information on the therapeutics...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.